系统性重症监护病房分诊对法国危重老年患者长期死亡率的影响:一项随机临床试验
这项多中心整群随机临床试验纳入3037例75岁及以上、无癌症、功能状态保留(日常生活活动独立性指数≥4)且营养状态保留(无恶病质)的危重患者,2012年1月至2015年4月就诊于法国24家医院急诊科,随访至2015年11月。中心随机分为推动系统性ICU收入项目组(n=1519)或标准实践组(n=1518)。主要终点6个月死亡在系统性策略组升高(45% vs 39%;RR 1.16;95%CI 1.07-1.26),ICU收入率增加(61% vs 34%;RR 1.80;95%CI 1.66-1.95)。调整基线特征后,系统性策略组ICU收入可能性更高(RR 1.68;95%CI 1.54-1.82),院内死亡风险更高(RR 1.18;95%CI 1.03-1.33),但6个月死亡风险无显著增加(RR 1.05;95%CI 0.96-1.14)。6个月功能状态和躯体生活质量组间无显著差异。
要点
- 系统性推动ICU收入的项目使ICU收入率从34%升至61%(RR 1.80;95%CI 1.66-1.95),但6个月死亡率未降低。
- 未调整分析中系统性策略组6个月死亡风险升高(45% vs 39%;RR 1.16;95%CI 1.07-1.26)。
- 调整基线特征后,系统性策略组院内死亡风险升高(RR 1.18;95%CI 1.03-1.33),6个月死亡风险无显著增加(RR 1.05;95%CI 0.96-1.14)。
- 6个月功能状态和躯体生活质量在两组间无显著差异。
- 作者结论认为,在法国危重老年患者中,推动系统性ICU收入的项目增加了ICU使用但未降低6个月死亡率,需要进一步研究理解老年患者收入ICU的决策。
适用人群与场景
- 75岁及以上、无癌症、功能状态保留(日常生活活动独立性指数≥4)且营养状态保留(无恶病质)的危重患者,就诊于法国24家医院急诊科,2012年1月至2015年4月纳入,随访至2015年11月。
研究设计与关键结果
- 多中心整群随机临床试验,纳入3037例患者(1例撤回知情同意后3036例分析;中位年龄85岁[四分位距81-89],男性1361例[45%]),中心随机分为系统性ICU收入推动项目组(n=1519)或标准实践组(n=1518)。
- 主要终点6个月死亡:系统性策略组45% vs 标准实践组39%(RR 1.16;95%CI 1.07-1.26)。
- ICU收入率:系统性策略组61% vs 标准实践组34%(RR 1.80;95%CI 1.66-1.95)。
- 调整基线特征后,系统性策略组ICU收入可能性更高(RR 1.68;95%CI 1.54-1.82),院内死亡风险更高(RR 1.18;95%CI 1.03-1.33),6个月死亡风险无显著增加(RR 1.05;95%CI 0.96-1.14)。
- 6个月功能状态和躯体生活质量两组间无显著差异。
证据类型、等级与局限
- 证据类型:多中心整群随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在法国危重老年患者中,推动系统性ICU收入的项目增加了ICU使用但未降低6个月死亡率;需要进一步研究以理解老年患者收入ICU的决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The high mortality rate in critically ill elderly patients has led to questioning of the beneficial effect of intensive care unit (ICU) admission and to a variable ICU use among this population.
OBJECTIVE: To determine whether a recommendation for systematic ICU admission in critically ill elderly patients reduces 6-month mortality compared with usual practice.
DESIGN, SETTING, AND PARTICIPANTS: Multicenter, cluster-randomized clinical trial of 3037 critically ill patients aged 75 years or older, free of cancer, with preserved functional status (Index of Independence in Activities of Daily Living ≥4) and nutritional status (absence of cachexia) who arrived at the emergency department of one of 24 hospitals in France between January 2012 and April 2015 and were followed up until November 2015.
INTERVENTIONS: Centers were randomly assigned either to use a program to promote systematic ICU admission of patients (n=1519 participants) or to follow standard practice (n=1518 participants).
MAIN OUTCOMES AND MEASURES: The primary outcome was death at 6 months. Secondary outcomes included ICU admission rate, in-hospital death, functional status, and quality of life (12-Item Short Form Health Survey, ranging from 0 to 100, with higher score representing better self-reported health) at 6 months.
RESULTS: One patient withdrew consent, leaving 3036 patients included in the trial (median age, 85 [interquartile range, 81-89] years; 1361 [45%] men). Patients in the systematic strategy group had an increased risk of death at 6 months (45% vs 39%; relative risk [RR], 1.16; 95% CI, 1.07-1.26) despite an increased ICU admission rate (61% vs 34%; RR, 1.80; 95% CI, 1.66-1.95). After adjustments for baseline characteristics, patients in the systematic strategy group were more likely to be admitted to an ICU (RR, 1.68; 95% CI, 1.54-1.82) and had a higher risk of in-hospital death (RR, 1.18; 95% CI, 1.03-1.33) but had no significant increase in risk of death at 6 months (RR, 1.05; 95% CI, 0.96-1.14). Functional status and physical quality of life at 6 months were not significantly different between groups.
CONCLUSIONS AND RELEVANCE: Among critically ill elderly patients in France, a program to promote systematic ICU admission increased ICU use but did not reduce 6-month mortality. Additional research is needed to understand the decision to admit elderly patients to the ICU.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01508819.
参考来源
- Guidet B, Leblanc G, Simon T, et al. Effect of Systematic Intensive Care Unit Triage on Long-term Mortality Among Critically Ill Elderly Patients in France: A Randomized Clinical Trial. JAMA. 2017. PMID: 28973065. doi:10.1001/jama.2017.13889
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。